Skip to main content
Download PDF

Volume 11 Supplement 1

16th Interntional Conference on Human Retroviruses: HTLV and Related Viruses

  • Oral presentation
  • Open access
  • Published:

Can we cure ATL: new drugs and targeting ATL stem cells

Retrovirology volume 11, Article number: O33 (2014) Cite this article

No abstract submitted

Author information

Authors and Affiliations

  1. Department of adult hematology, laboratory of physiopathology and treatment of hematological disorders, Institut Imagine, University of Sorbonne Paris Cite, Necker Hospital, Paris, France

    Olivier Hermine

Authors
  1. Olivier Hermine
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Cite this article

Hermine, O. Can we cure ATL: new drugs and targeting ATL stem cells. Retrovirology 11 (Suppl 1), O33 (2014). https://doi.org/10.1186/1742-4690-11-S1-O33

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/1742-4690-11-S1-O33

Keywords

Retrovirology

ISSN: 1742-4690

Contact us